278 related articles for article (PubMed ID: 24740790)
1. Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.
Hall G; Rowell J; Farinelli F; Gbadegesin RA; Lavin P; Wu G; Homstad A; Malone A; Lindsey T; Jiang R; Spurney R; Tomaselli GF; Kass DA; Winn MP
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1442-50. PubMed ID: 24740790
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6.
Takahashi S; Lin H; Geshi N; Mori Y; Kawarabayashi Y; Takami N; Mori MX; Honda A; Inoue R
J Physiol; 2008 Sep; 586(17):4209-23. PubMed ID: 18617565
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury.
't Hart D; Li J; van der Vlag J; Nijenhuis T
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830371
[TBL] [Abstract][Full Text] [Related]
10. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling.
Chen L; Tang YL; Liu ZH; Pan Y; Jiao RQ; Kong LD
Eur J Pharmacol; 2021 Dec; 913():174616. PubMed ID: 34780752
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
12. Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes.
Chi-Xianggeng ; Hu-Bo ; Yu SY; Yin-Lianghong ; Meng-Yu ; Wang-Boxun ; Yang-Jinsheng ; Lin-Jiahui ; Huang-Dexu ; Chen-Lanlan
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1118-24. PubMed ID: 25795457
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil Prevents Podocyte Injury
Sonneveld R; Hoenderop JG; Isidori AM; Henique C; Dijkman HB; Berden JH; Tharaux PL; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2017 May; 28(5):1491-1505. PubMed ID: 27895156
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
15. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
[TBL] [Abstract][Full Text] [Related]
16. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
[TBL] [Abstract][Full Text] [Related]
18. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.
Zhang H; Ding J; Fan Q; Liu S
Exp Biol Med (Maywood); 2009 Sep; 234(9):1029-36. PubMed ID: 19546355
[TBL] [Abstract][Full Text] [Related]
19. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.
Wang J; Yang K; Xu L; Zhang Y; Lai N; Jiang H; Zhang Y; Zhong N; Ran P; Lu W
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):231-40. PubMed ID: 23526219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
